CAT
70
-7
DVN
40
-4
OXY
42
-4
WHR
55
-6
QCOM
46
-3
VLO
76
13
RL
70
-2
BF.B
33
-3
LYB
30
-6
CL
32
-11
HBAN
82
-3
SWK
65
-6
OI
56
-13
WM
59
-3
FCX
81
-2
HIG
60
-3
CA
56
3
MAS
52
-3
PHM
53
-2
GRMN
42
2
CAT
70
-7
DVN
40
-4
OXY
42
-4
WHR
55
-6
QCOM
46
-3
VLO
76
13
RL
70
-2
BF.B
33
-3
LYB
30
-6
CL
32
-11
HBAN
82
-3
SWK
65
-6
OI
56
-13
WM
59
-3
FCX
81
-2
HIG
60
-3
CA
56
3
MAS
52
-3
PHM
53
-2
GRMN
42
2
Financhill
Back

FlexShares High Yield Value-Scored Bond Index Fund Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison

Sell
49

HYGV
FlexShares High Yield Value-Scored Bond Index Fund

Last Price:
$40.92
Seasonality Move:
-2.25%
Buy
75

DRUG
Bright Minds Biosciences, Inc.

Last Price:
$90.03
Seasonality Move:
-24.59%
Sell
49
FlexShares High Yield Value-Scored Bond Index Fund (HYGV) is a Sell

Is FlexShares High Yield Value-Scored Bond Index Fund a Buy, Sell or Hold?

  • The current FlexShares High Yield Value-Scored Bond Index Fund [HYGV] share price is $40.89. The Score for HYGV is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • HYGV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Bright Minds Biosciences, Inc. (DRUG) is a Buy

Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?

  • The current Bright Minds Biosciences, Inc. [DRUG] share price is $95.99. The Score for DRUG is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • DRUG is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

HYGV Stock Price Chart

What is FlexShares High Yield Value-Scored Bond Index Fund's stock price today?

  • The FlexShares High Yield Value-Scored Bond Index Fund share price today is $40.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HYGV is experiencing selling pressure, which indicates risk of future bearish movement.

DRUG Stock Price Chart

What is Bright Minds Biosciences, Inc.'s stock price today?

  • The Bright Minds Biosciences, Inc. share price today is $95.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.

HYGV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 57.33 Buy
Chaikin Money Flow: -50797 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.69 - 40.87) Buy
Bollinger Bands (100): (40.66 - 41.06) Buy

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.7 Buy
Relative Strength Index (14 RSI): 65.61 Buy
Chaikin Money Flow: 292843 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.33 - 88.51) Buy
Bollinger Bands (100): (45.68 - 74.86) Buy

HYGV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.8 Buy
20-day SMA: 40.77 Buy
50-day SMA: 40.77 Buy
200-day SMA: 40.57 Buy
8-day EMA: 40.82 Buy
20-day EMA: 40.78 Buy
50-day EMA: 40.29 Buy
200-day EMA: 27.24 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.5 Buy
20-day SMA: 83.91 Buy
50-day SMA: 69.69 Buy
200-day SMA: 45.45 Buy
8-day EMA: 85.95 Buy
20-day EMA: 81.76 Buy
50-day EMA: 72.81 Buy
200-day EMA: 51.04 Buy

FlexShares High Yield Value-Scored Bond Index Fund Earnings Growth & HYGV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.93 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.27 per share, and a decrease next year of $1.59 per share.

FlexShares High Yield Value-Scored Bond Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):